Effect of obesity on parameters of ovarian reserve in premenopausal women.

Objective: To study the relationship between obesity and serum and ultrasound markers of ovarian reserve in premenopausal women.

Methods: We performed a cross-sectional comparative study of two age-matched groups of premenopausal participants (early transition phase): 50 participants ("non-obese") had a BMI < 30 kg/m2, and the other 50 participants ("obese") had a BMI of 30 to 35 kg/m2. The obese women had a mean age of 46.

Assessment of male serum anti-Mullerian hormone as a marker of spermatogenesis and ICSI outcome.

Objective: To assess serum anti-Mullerian hormone (AMH) as a marker of spermatogenesis among fertile and infertile males, as well as its relation to ICSI outcome.

Methods: A total of 77 male partners of infertile couples seeking infertility treatment were recruited for this study. They were classified according to the WHO criteria of semen analysis into three groups; azospermia, oligospermia, and normal.

Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome.

In the human ovary, expression of anti-Müllerian hormone (AMH) is detected primarily in granulosa cells of preantral and small antral follicles. The aim of this study was to compare serum AMH measurements in obese women with polycystic ovary syndrome (PCOS) with those in obese normo-ovulatory women and to evaluate the role of AMH as a predictor of ovulation induction by clomiphene citrate compared to FSH. Sixty-eight obese women with PCOS were compared to 17 normoovulatory obese women.